CHEMBL45158806A-HYDROXY-ANDROST-4-ENE-3,17-DIONEAndrost-4-ene-3,17-dione, 6-hydroxy-, (6.beta.)-6?-Hydroxy Androstenedione6beta-Hydroxy Androstenedione (1mg/ml in Methanol)6|A-Hydroxy AndrostenedioneUNII-7E9225W0A9(6R,8R,9S,10R,13S,14S)-6-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione
Properties
Computed structural propertiesFilling in
XLogP
1.5
Topological polar surface area
54.4 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
0
Heavy atoms
22
Formal charge
0
Complexity
577
Physicochemical properties
Melting point
192 · 192-194 °C
Boiling point
479.1 · 479.1±45.0 °C(Predicted)
Density
1.19 · 1.19±0.1 g/cm3(Predicted)
solubility
Chloroform (Slightly), Methanol (Slightly)
form
Solid
pka
14.03 · 14.03±0.60(Predicted)
color
White to Off-White
FDA UNII
7 E9225W0A9 · 7E9225W0A9
Safety & regulation
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Hazard information
Regulatory InformationAndrost-4-ene-3,17-dione, 6-hydroxy-, (6.beta.)-: Does not have an individual approval but may be used under an appropriate group standard
Regulatory information
Regulatory InformationAndrost-4-ene-3,17-dione, 6-hydroxy-, (6.beta.)-: Does not have an individual approval but may be used under an appropriate group standard